Figure 1 Years of first clinical study and approval for therapeutic monoclonal antibodies. *Two-year moving average. FDA, United States Food and Drug Administration.
Table 1 Therapeutic monoclonal antibodies undergoing regulatory review or approved in the United States
Table 2 Mean (median) clinical and FDA approval phases for 23 therapeutic monoclonal antibodiesTable Footnote*
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.